2023 Kidney Cancer Research Summit Abstracts

The 5(th) Kidney Cancer Research Summit (KCRS) took place on July 13(th) & 14(th), 2023 as a hybrid event both in Boston, Massachusetts at the InterContinental Boston, and virtually via Zoom webinar. The conference format consisted of oral presentations in an intimate setting that enables dynamic discussion among attendees. Sessions included Modulating the Tumor Microenvironment, Biology of Non-Clear Cell Renal Cancer Subtypes, Clinical Trials in Progress, Breaking Barriers to Trial Enrollment, Clinical and Scientific Updates, Immunotherapy Advances and Research, Oral Abstracts, and Rapid Abstracts. Additionally, there was also a symposium on the current state of development of kidney cancer biomarkers, one of the greatest unmet needs for a malignancy with multiple approved drugs and combinations. KCRS was inaugurated in 2019 to congregate the community of researchers conducting projects involving kidney cancer with clinicians, industry partners, and patient advocates in order to foster new collaborations and generate constructive feedback. KCRS is funded through sponsors, partnerships, and grassroots supporters organized by KidneyCAN, a nationwide network of individuals with kidney cancer, caregivers, and family members who are committed to accelerating cures for kidney cancer. Basic through translational and clinical research are included, and the program is centered on projects funded through the Department of Defense’s Kidney Cancer Research Program awards. The goal is to give current and future projects the best chance to succeed and ensure the orientation of goals towards raising the standard of care and improving patient outcomes across all histological subtypes and stages of this disease. This supplement contains a complete list of scheduled abstract presentations that were accepted as of June 9(th), 2023. Please be aware that some abstracts may have been withdrawn or rescheduled at the authors’ request.